Firstmed Pipeline – Our Medicines in Development
Our pipeline of new medicines and Nutritional Medicine food products in development is , focusing on a small range of unmet medical needs spanning 3 Therapeutic Areas. Firstmed invests in the research and development of new products across several therapeutic areas. Relying on the strength of our pipeline and scientific talent, Firstmed has generated a steady stream of breakthroughs over the years. Our researchers continue to work around the clock and around the globe to ensure the best medicines for our patients in the years to come.
Cardiovascular, Metabolic and Endocrine Diseases
Chronic cardiovascular disease and diabetes cause one of every three deaths in the world today. Unless breakthroughs are made, the growing prevalence of diabetes and obesity will greatly add to the human and economic cost of disease over the next 20 years. Advances in understanding risk factors and in the development of new therapies have demonstrated that cardiovascular disease is largely preventable. Firstmed´s current and future portfolio of medicines in this Therapeutic Area focuses on the control of the risk factors inherent in smoking, diet, physical inactivity, and Type 2 diabetes.
Gastrointestinal Diseases / Immune System Response
Digestive and liver diseases are a source of signiﬁcant morbidity, mortality, and health-care costs for the U.S. population. In response, Firstmed is working to help these patients.Areas of intense focus are in
- Inflammatory bowel disease
- Irritable bowel syndromee
- Severe food allergies
Our work is focused on newly discovered Flavonoids, Tannins and Phenolic compounds showing anti tumor activity with great promise for the prevention of certain types of Cancer like Mama, Prostate, and Colon.
The result of this means better preventive care and treatment protocols which may increases the patients quality of life. The impact of this is not only felt by patients but also family and friends .